0R3M.L
Vivoryon Therapeutics N.V. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutic solutions for Alzheimer's disease. Their primary strategy involves targeting and inhibiting the production of toxic pyroglutamate-Abeta (pGlu-Abeta). The company's lead investigational compound, PQ912, is a small molecule QC inhibitor. This candidate has successfully completed Phase IIb clinical trials for both Alzheimer's disease and cancer. In its preclinical pipeline, Vivoryon is advancing PQ1565, a small molecule glutaminyl-peptide cyclotransferase-like inhibitor, specifically for cancer treatment. Additionally, the firm is developing a monoclonal antibody designed to e...[Read more]
Industry
Biotechnology
IPO Date
2015-04-23
Stock Exchange
LSE
Ticker
0R3M.L
According to Vivoryon Therapeutics N.V.’s latest financial reports and current stock price. The company's current Current Ratio is 4.56. This represents a change of -22.27% compared to the average of 5.87 of the last 4 quarters.
The mean historical Current Ratio of Vivoryon Therapeutics N.V. over the last ten years is 13.26. The current 4.56 Current Ratio has changed 3.34% with respect to the historical average. Over the past ten years (40 quarters), 0R3M.L's Current Ratio was at its highest in in the June 2020 quarter at 56.68. The Current Ratio was at its lowest in in the June 2011 quarter at 0.
Average
13.26
Median
8.52
Minimum
4.00
Maximum
48.79
Discovering the peaks and valleys of Vivoryon Therapeutics N.V. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.08%
Maximum Annual Current Ratio = 48.79
Minimum Annual Increase = -81.57%
Minimum Annual Current Ratio = 4.00
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 7.68 | 6.71% |
| 2024 | 7.20 | -23.19% |
| 2023 | 9.37 | -0.34% |
| 2022 | 9.40 | 134.73% |
| 2021 | 4.00 | -81.57% |
| 2020 | 21.73 | -55.46% |
| 2019 | 48.79 | 1.08% |
| 2018 | 4.13 | -74.20% |
| 2017 | 16.01 | 270.64% |
| 2016 | 4.32 | -2.38% |
The current Current Ratio of Vivoryon Therapeutics N.V. (0R3M.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.08
5-year avg
7.53
10-year avg
13.26
Vivoryon Therapeutics N.V.’s Current Ratio is greater than Celyad Oncology S.A. (1.92), greater than Paion AG (1.41), greater than AB Science S.A. (0.96), greater than BioSenic S.A. (0.55), greater than MPH Health Care AG (0.17), less than Transgene S.A. (9.62),
| Company | Current Ratio | Market cap |
|---|---|---|
| 1.92 | N/A | |
| 1.41 | N/A | |
| 0.96 | N/A | |
| 0.55 | N/A | |
| 0.17 | N/A | |
| 9.62 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vivoryon Therapeutics N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vivoryon Therapeutics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Vivoryon Therapeutics N.V.'s Current Ratio?
How is the Current Ratio calculated for Vivoryon Therapeutics N.V. (0R3M.L)?
What is the highest Current Ratio for Vivoryon Therapeutics N.V. (0R3M.L)?
What is the 3-year average Current Ratio for Vivoryon Therapeutics N.V. (0R3M.L)?
What is the 5-year average Current Ratio for Vivoryon Therapeutics N.V. (0R3M.L)?
How does the current Current Ratio for Vivoryon Therapeutics N.V. (0R3M.L) compare to its historical average?